Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB.

Saved in:
Bibliographic Details
Title: Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB.
Authors: Su CM; Department of Surgery, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C., Li CH; Department of Orthopedics, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C., Huang MC; Department of Medical Imaging, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C., Yueh PF; Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.; Institute of Traditional Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C., Hsu FT; Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C., Lin RF; Department of Optometry, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C., Hsu LC; Department of Medicine, National Yang-Ming Chiao-Tung University Hospital, Yilan, Taiwan, R.O.C. hsulc@ymuh.ym.edu.tw.
Source: In vivo (Athens, Greece) [In Vivo] 2022 May-Jun; Vol. 36 (3), pp. 1136-1143.
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7549
DOI:10.21873/invivo.12812